ReviewTherapeutic advances in neurological disorders2019
The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis.
Martin Diebold et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it